Literature DB >> 18159929

Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response.

Amélie Moreau1, Marie José Vilarem, Patrick Maurel, Jean Marc Pascussi.   

Abstract

Xenobiotic and drug metabolism and transport are managed by a large number of genes coordinately regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR, NR1I3), and pregnane X receptor (PXR, NR1I2). Initially characterized as xenosensors, it is now evident that CAR and PXR also trigger pleiotropic effects on liver function. Recent studies have shown the existence of crosstalk between xenosensors and other nuclear receptors or transcription factors controlling endogenous signaling pathways which regulate physiological functions. This review is focused on recent observations showing that activation of CAR and PXR alters lipid metabolism, glucose homeostasis, and inflammation by interfering with HNF4alpha, FoxO1, FoxA2, PGC1alpha, or NFkB p65. Such crosstalks explain clinical observations and provide molecular mechanisms allowing understanding how xenobiotics and drugs may affect physiological functions and provoke endocrine disruptions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18159929     DOI: 10.1021/mp700103m

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  70 in total

1.  Evolutionary history and functional characterization of the amphibian xenosensor CAR.

Authors:  Marianne Mathäs; Oliver Burk; Huan Qiu; Christian Nusshag; Ute Gödtel-Armbrust; Dorothea Baranyai; Shiwei Deng; Kristin Römer; Dieudonné Nem; Björn Windshügel; Leszek Wojnowski
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands.

Authors:  Ann M Dring; Linnea E Anderson; Saima Qamar; Matthew A Stoner
Journal:  Chem Biol Interact       Date:  2010-10-20       Impact factor: 5.192

Review 3.  Sterol regulation of metabolism, homeostasis, and development.

Authors:  Joshua Wollam; Adam Antebi
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

4.  Cytochromes P450, induction and cholesterol--what are the connections?

Authors:  Olavi Pelkonen; Jukka Hakkola
Journal:  Eur J Clin Pharmacol       Date:  2008-07-17       Impact factor: 2.953

Review 5.  A structural view of nuclear hormone receptor: endocrine disruptor interactions.

Authors:  Albane le Maire; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2010-01-09       Impact factor: 9.261

6.  Gender disparity of hepatic lipid homoeostasis regulated by the circadian clock.

Authors:  Xiaoxia Yang; Yu-Kun Jennifer Zhang; Noriko Esterly; Curtis D Klaassen; Yu-Jui Yvonne Wan
Journal:  J Biochem       Date:  2009-01-27       Impact factor: 3.387

7.  Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation.

Authors:  Joo-Youn Cho; Dong Wook Kang; Xiaochao Ma; Sung-Hoon Ahn; Kristopher W Krausz; Hans Luecke; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2009-01-13       Impact factor: 5.922

8.  Rifampicin Inhibits the LPS-induced Expression of Toll-like Receptor 2 via the Suppression of NF-kappaB DNA-binding Activity in RAW 264.7 Cells.

Authors:  Seong Keun Kim; Young Mi Kim; Chung Eun Yeum; Song-Hyo Jin; Gue Tae Chae; Seong-Beom Lee
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

9.  Sex-Differential Responses of Tumor Promotion-Associated Genes and Dysregulation of Novel Long Noncoding RNAs in Constitutive Androstane Receptor-Activated Mouse Liver.

Authors:  Nicholas J Lodato; Tisha Melia; Andy Rampersaud; David J Waxman
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

10.  Protein expression analysis of inflammation-related colon carcinogenesis.

Authors:  Yumiko Yasui; Takuji Tanaka
Journal:  J Carcinog       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.